Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man
Armand Keating(University Health Network), Philip J. Fialkow(University of Washington Medical Center), Jack W. Singer(NorthShore University HealthSystem), Paul D. Killen(University of Washington Medical Center), Jean E. Sanders(Carolinas Medical Center), Gary E. Striker(National Institutes of Health), David Thorning(University of Washington Medical Center), E. Donnall Thomas(AbbVie (United States)), Armi Salo(University of Washington Medical Center)
Cited by 254
Related Papers
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Antileukemic Effect of Chronic Graft-versus-Host Disease
|New England Journal of Medicine|1981|1.1k
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
|New England Journal of Medicine|1993|848